Invention Grant
- Patent Title: Potassium channel inhibitors
-
Application No.: US16078128Application Date: 2017-02-23
-
Publication No.: US11274092B2Publication Date: 2022-03-15
- Inventor: Ulrik Svane Sørensen , Antonio Mete
- Applicant: ACESION PHARMA ApS
- Applicant Address: DK Copenhagen N
- Assignee: ACESION PHARMA ApS
- Current Assignee: ACESION PHARMA ApS
- Current Assignee Address: DK Copenhagen N
- Agency: Maier & Maier, PLLC
- Priority: EP16020053 20160224
- International Application: PCT/EP2017/025033 WO 20170223
- International Announcement: WO2017/144183 WO 20170831
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D405/12 ; C07D413/12 ; C07D403/12 ; C07D417/12 ; C07D491/107 ; C07D235/30 ; A61P9/00 ; A61P9/06 ; A61P9/10
Abstract:
The present invention relates to a compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
Public/Granted literature
- US20210188804A1 NOVEL POTASSIUM CHANNEL INHIBITORS Public/Granted day:2021-06-24
Information query
